FDA Approves Novel ADHD Medication Centanafadine, SIMTRIYO, Offering New Hope for Patients with Limited Options
"Centanafadine’s FDA approval marks a significant advancement for individuals with ADHD who have struggled with existing treatments, particularly those intolerant to stimulants or unresponsive to current non-stimulant options, though long-term…